Revvity Inc. (NYSE:RVTY) Receives $107.73 Average Target Price from Brokerages

Shares of Revvity Inc. (NYSE:RVTY) have been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $108.3333.

RVTY has been the subject of a number of recent analyst reports. Wolfe Research initiated coverage on Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. TD Cowen upped their price target on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Finally, Barclays upped their price target on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. EdgePoint Investment Group Inc. raised its position in shares of Revvity by 26.3% in the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock worth $751,536,000 after acquiring an additional 1,784,620 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Revvity by 127.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after acquiring an additional 980,142 shares in the last quarter. Norges Bank bought a new position in shares of Revvity in the 4th quarter worth approximately $80,382,000. Morgan Stanley raised its position in shares of Revvity by 29.6% in the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock worth $275,202,000 after acquiring an additional 650,083 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Revvity by 39.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after acquiring an additional 596,436 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Down 0.0%

Shares of RVTY stock opened at $112.99 on Wednesday. The stock has a market capitalization of $12.60 billion, a PE ratio of 54.06, a P/E/G ratio of 2.47 and a beta of 1.11. Revvity has a 1-year low of $81.22 and a 1-year high of $118.30. The business has a 50-day moving average of $97.46 and a 200 day moving average of $97.74. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.Revvity’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, sell-side analysts anticipate that Revvity will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio is presently 13.40%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.